Literature DB >> 18716885

Is it possible to estimate the incidence of breast cancer from medico-administrative databases?

L Remontet1, N Mitton, C M Couris, J Iwaz, F Gomez, F Olive, S Polazzi, A M Schott, B Trombert, N Bossard, M Colonna.   

Abstract

One approach to estimate cancer incidence in the French Départements is to quantify the relationship between data in cancer registries and data obtained from the PMSI (Programme de Médicalisation des Systèmes d'Information Médicale). This relationship may then be used in Départements without registries to infer the incidence from local PMSI data. We present here some methodological solutions to apply this approach. Data on invasive breast cancer for 2002 were obtained from 12 Départemental registries. The number of hospital stays was obtained from the National PMSI using two different algorithms based on the main diagnosis only (Algorithm 1) or on that diagnosis associated to a mention of "resection" (Algorithm 2). Considering registry data as gold standard, a calibration approach was used to model the ratio of the number of hospital stays to the number of incident cases. In Départements with registries, validation of the predictions was done through cross-validation. In Départements without registries, validation was done through a study of homogeneity of the mean number of hospital stays per patient. Cross-validation showed that the estimates predicted by the model were true with data extracted by Algorithm 1 but not by Algorithm 2. However, with Algorithm 1, there was an important heterogeneity between French Départements as to the mean number of hospital stays per patient, which had an important impact on the estimations. In the near future, the method will allow using medico-administrative data (after calibration with registry data) to estimate Départemental incidence of selected cancers.

Entities:  

Mesh:

Year:  2008        PMID: 18716885     DOI: 10.1007/s10654-008-9282-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  Evaluation of an algorithm to identify incident breast cancer cases using DRGs data.

Authors:  O Ganry; A Taleb; J Peng; N Raverdy; A Dubreuil
Journal:  Eur J Cancer Prev       Date:  2003-08       Impact factor: 2.497

2.  Ability of Medicare claims data and cancer registries to identify cancer cases and treatment.

Authors:  D K McClish; L Penberthy; M Whittemore; C Newschaffer; D Woolard; C E Desch; S Retchin
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

3.  Cancer incidence and mortality in France over the period 1978-2000.

Authors:  L Remontet; J Estève; A-M Bouvier; P Grosclaude; G Launoy; F Menegoz; C Exbrayat; B Tretare; P-M Carli; A-V Guizard; X Troussard; P Bercelli; M Colonna; J-M Halna; G Hedelin; J Macé-Lesec'h; J Peng; A Buemi; M Velten; E Jougla; P Arveux; L Le Bodic; E Michel; M Sauvage; C Schvartz; J Faivre
Journal:  Rev Epidemiol Sante Publique       Date:  2003-02       Impact factor: 1.019

4.  Determination of lung cancer incidence in the elderly using Medicare claims data.

Authors:  A M McBean; J D Babish; J L Warren
Journal:  Am J Epidemiol       Date:  1993-01-15       Impact factor: 4.897

5.  The sensitivity of Medicare claims data for case ascertainment of six common cancers.

Authors:  G S Cooper; Z Yuan; K C Stange; L K Dennis; S B Amini; A A Rimm
Journal:  Med Care       Date:  1999-05       Impact factor: 2.983

6.  Use of Medicare claims data to measure county-level variation in breast carcinoma incidence and mammography rates.

Authors:  Gregory S Cooper; Zhong Yuan; Reena N Jethva; Alfred A Rimm
Journal:  Cancer Detect Prev       Date:  2002

7.  [Sensitivity and specificity of two methods used to identify incident breast cancer in specialized units using claims databases].

Authors:  C M Couris; C Forêt-Dodelin; M Rabilloud; C Colin; J-Y Bobin; D Dargent; D Raudrant; A-M Schott
Journal:  Rev Epidemiol Sante Publique       Date:  2004-04       Impact factor: 1.019

8.  Cancer incidence and mortality in France over the period 1980-2005.

Authors:  A Belot; P Grosclaude; N Bossard; E Jougla; E Benhamou; P Delafosse; A-V Guizard; F Molinié; A Danzon; S Bara; A-M Bouvier; B Trétarre; F Binder-Foucard; M Colonna; L Daubisse; G Hédelin; G Launoy; N Le Stang; M Maynadié; A Monnereau; X Troussard; J Faivre; A Collignon; I Janoray; P Arveux; A Buemi; N Raverdy; C Schvartz; M Bovet; L Chérié-Challine; J Estève; L Remontet; M Velten
Journal:  Rev Epidemiol Sante Publique       Date:  2008-06-10       Impact factor: 1.019

9.  Estimating incidence of cancer from a hospital discharge reporting system.

Authors:  P Toniolo; P Pisani; C Vigano; G Gatta; F Repetto
Journal:  Rev Epidemiol Sante Publique       Date:  1986       Impact factor: 1.019

10.  In the absence of cancer registry data, is it sensible to assess incidence using hospital separation records?

Authors:  Moyra E Brackley; Margaret J Penning; Mary L Lesperance
Journal:  Int J Equity Health       Date:  2006-10-06
View more
  6 in total

1.  Assessment of the French National Health Insurance Information System as a tool for epidemiological surveillance of malaria.

Authors:  François Delon; Aurélie Mayet; Marc Thellier; Eric Kendjo; Rémy Michel; Lénaïck Ollivier; Gilles Chatellier; Guillaume Desjeux
Journal:  J Am Med Inform Assoc       Date:  2017-05-01       Impact factor: 4.497

2.  A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry.

Authors:  Nicolas Mitton; Marc Colonna; Béatrice Trombert; Frédéric Olive; Frédéric Gomez; Jean Iwaz; Stéphanie Polazzi; Anne-Marie Schott-Petelaz; Zoé Uhry; Nadine Bossard; Laurent Remontet
Journal:  J Cancer Epidemiol       Date:  2011-03-08

3.  Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry.

Authors:  Aurore Palmaro; Martin Gauthier; Cécile Conte; Pascale Grosclaude; Fabien Despas; Maryse Lapeyre-Mestre
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Validation study: evaluation of the metrological quality of French hospital data for perinatal algorithms.

Authors:  Karine Goueslard; Jonathan Cottenet; Eric Benzenine; Pascale Tubert-Bitter; Catherine Quantin
Journal:  BMJ Open       Date:  2020-05-12       Impact factor: 2.692

5.  Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.

Authors:  Jean-Paul Fagot; Pierre-Olivier Blotière; Philippe Ricordeau; Alain Weill; François Alla; Hubert Allemand
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

6.  Estimation of national colorectal-cancer incidence using claims databases.

Authors:  C Quantin; E Benzenine; M Hägi; B Auverlot; M Abrahamowicz; J Cottenet; E Fournier; C Binquet; D Compain; E Monnet; A M Bouvier; A Danzon
Journal:  J Cancer Epidemiol       Date:  2012-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.